Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Brenda B. Rush"'
Autor:
Robert D. Burk, Sholom Wacholder, Attila T. Lorincz, Peter Kirk, Greg Rydzak, Mark E. Sherman, Julie Buckland, David R. Scott, Philip E. Castle, Brenda B. Rush, Nicolas Wentzensen, Andrew G. Glass, Mark Schiffman
PDF file - 219K.Please Note: Supplementary Table 1 was updated 06/20/12. Please see the published correction notice for details of modifications to the article made in order to correct author error.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e0e5fc56961703026eb79f6cb6ace8e
https://doi.org/10.1158/1055-9965.22435911
https://doi.org/10.1158/1055-9965.22435911
Autor:
Robert D. Burk, Sholom Wacholder, Attila T. Lorincz, Peter Kirk, Greg Rydzak, Mark E. Sherman, Julie Buckland, David R. Scott, Philip E. Castle, Brenda B. Rush, Nicolas Wentzensen, Andrew G. Glass, Mark Schiffman
PDF file - 164K
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::33e745372cc5be656cbf6d66ed7361d1
https://doi.org/10.1158/1055-9965.22435908.v1
https://doi.org/10.1158/1055-9965.22435908.v1
Autor:
Robert D. Burk, Sholom Wacholder, Attila T. Lorincz, Peter Kirk, Greg Rydzak, Mark E. Sherman, Julie Buckland, David R. Scott, Philip E. Castle, Brenda B. Rush, Nicolas Wentzensen, Andrew G. Glass, Mark Schiffman
Background: Human papillomavirus (HPV) DNA testing is more sensitive than cytology for detection of cervical intraepithelial neoplasia grade 3 and cancer (≥CIN3). Adding HPV testing to cytology is recommended for women ≥30 but long-term prospecti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2dba4bf252668394138d9a8537a4e0e
https://doi.org/10.1158/1055-9965.c.6515160.v1
https://doi.org/10.1158/1055-9965.c.6515160.v1
Autor:
J. Keith Killian, Jamie N. Bakkum-Gamez, Karl C. Podratz, Hannah P. Yang, Jolanta Lissowska, Munira Gunja, Andrew G. Glass, Richard S. Guido, Nicolas Wentzensen, Brenda B. Rush, James V. Lacey, Patricia Luhn, Louise A. Brinton, Lori D'Ambrosio, Paul S. Meltzer, Joshua N. Sampson, Viji Shridhar, Lisa G. Adams, Mark E. Sherman, Montserrat Garcia-Closas
Publikováno v:
International Journal of Cancer. 135:1860-1868
The prognosis of endometrial cancer is strongly associated with stage at diagnosis, suggesting that early detection may reduce mortality. Women who are diagnosed with endometrial carcinoma often have a lengthy history of vaginal bleeding, which offer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5baf10226dab67f3de86d80d53cdbf2a
https://doi.org/10.1002/ijc.28843
https://doi.org/10.1002/ijc.28843
Autor:
Brenda B. Rush, Mark E. Sherman, Nilanjan Chatterjee, Brigitte M. Ronnett, Andrew G. Glass, Douglas A. Richesson, Bryan Langholz, Olga B. Ioffe, James V. Lacey, Máire A. Duggan
Publikováno v:
Journal of Clinical Oncology. 28:788-792
Purpose The severity of endometrial hyperplasia (EH)—simple (SH), complex (CH), or atypical (AH)—influences clinical management, but valid estimates of absolute risk of clinical progression to carcinoma are lacking. Materials and Methods We condu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::156a08b63a240e0a58aa90bd593f5304
https://doi.org/10.1200/jco.2009.24.1315
https://doi.org/10.1200/jco.2009.24.1315
Autor:
Andrew G. Glass, James V. Lacey, Máire A. Duggan, Douglas A. Richesson, Brenda B. Rush, Mark E. Sherman, Nilanjan Chatterjee, Brigitte M. Ronnett, Olga B. Ioffe
Publikováno v:
International Journal of Gynecological Pathology. 27:318-325
Background: Identifying which categories in the World Health Organization classification of endometrial hyperplasia contribute to suboptimal reproducibility is clinically important. Methods: A 2-member panel reviewed 209 endometrial biopsy/curettage
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::59c9df89a90cb8fa6f0c697ab93f6021
https://doi.org/10.1097/pgp.0b013e3181659167
https://doi.org/10.1097/pgp.0b013e3181659167
Autor:
Mark E. Sherman, Brenda B. Rush, Douglas A. Richesson, Brigitte M. Ronnett, James V. Lacey, Nilanjan Chatterjee, Olga B. Ioffe, A. G. Glass, Bryan Langholz
Publikováno v:
British Journal of Cancer
Classifying endometrial hyperplasia (EH) according to the severity of glandular crowding (simple hyperplasia (SH) vs complex hyperplasia (CH)) and nuclear atypia (simple atypical hyperplasia (SAH) vs complex atypical hyperplasia (CAH)) should predict
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aae85e2f2816427dad8d24fa4fa27573
https://doi.org/10.1038/sj.bjc.6604102
https://doi.org/10.1038/sj.bjc.6604102
Autor:
Brenda B. Rush, Robert D. Burk, David R. Scott, Sholom Wacholder, Mark Schiffman, Andrew G. Glass, Anne Dunn, Philip E. Castle
Publikováno v:
The Journal of Infectious Diseases. 194:1702-1705
We compared human papillomavirus (HPV) prevalence in an age-stratified random sample of women who have undergone a hysterectomy (WH) (n=573) with the HPV prevalence in age-matched women with intact cervices (women who have not undergone a hysterectom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2066f6b604c9281b8b00f5493ff3c7cb
https://doi.org/10.1086/509511
https://doi.org/10.1086/509511
Publikováno v:
American Journal of Obstetrics and Gynecology. 191:114-120
The purpose of this study was to examine the health care costs of cervical human papillomavirus-related disease in a US health care setting.We conducted an observational cohort study using 1997 through 2002 administrative and laboratory records from
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54136bdf670da139d51849b58241fa38
https://doi.org/10.1016/j.ajog.2004.01.042
https://doi.org/10.1016/j.ajog.2004.01.042
Autor:
B S Franklin Demuth, David R. Scott, Brenda B. Rush, Mark Schiffman, Philip E. Castle, Attila T. Lorincz, Mark E. Sherman, Andrew G. Glass, Sholom Wacholder
Publikováno v:
Cancer. 95:2145-2151
BACKGROUND The addition of human papillomavirus (HPV) DNA testing to cytologic screening for cervical carcinoma is now being considered. The majority of women in screening cohorts who test positive for oncogenic types of HPV DNA have concurrent negat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b3a06d2ef3bc42b7925db7d310f3ecd
https://doi.org/10.1002/cncr.10927
https://doi.org/10.1002/cncr.10927